Overview

GSK618334 Repeat Dose Study

Status:
Completed

Trial end date:
2010-02-17

Target enrollment:

Participant gender:

Summary

The proposed study will evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics of repeated oral doses of GSK618334 in healthy male and female volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline